Navigation Links
Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
Date:3/28/2017

WASHINGTON, March 28, 2017 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Ipsen Biopharmaceuticals, Inc. has joined the health policy research organization as its newest member. David Cox, PhD, Vice President, Medical and Regulatory Affairs (North America), will serve as his company's representative on NPC's Board of Directors.

"We're pleased to have Ipsen and Dr. Cox join NPC as members," said NPC President Dan Leonard. "We welcome their insights in helping us identify and address health care priorities in today's rapidly changing policy environment."

Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen, a global specialty-driven pharmaceutical group focused on discovering, developing and commercializing new therapeutic options for oncologic, neurologic and endocrine diseases.

"At a time when all of us in health care are facing a number of challenges, we appreciate NPC's thoughtful, research-oriented approach in considering how to improve health system efficiencies and lower access barriers to high-value care, among other issues," said Dr. Cox. "We're looking forward to engaging with NPC on these important health care matters."

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

About Ipsen in North America
Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen, a global specialty-driven pharmaceutical group. The U.S. head office is located in Basking Ridge, New Jersey. Ipsen Biopharmaceuticals Canada, Inc. is an integrated business unit within North America and has its head office located in Mississauga, Ontario. Ipsen Bioscience, Inc., the Ipsen U.S. research and development center focused on peptide research in oncology and endocrinology, is located in Cambridge, Massachusetts. At Ipsen Bioscience, we focus on creating a highly cooperative and passionate R&D organization through partnerships, innovation, and continuous learning to effectively deliver new treatments for patients. At Ipsen, we focus our resources, investments, and energy on discovering, developing, and commercializing new therapeutic options for oncologic, neurologic, and endocrine diseases. For more information on Ipsen in North America, please visit www.ipsenus.com or www.ipsen.ca.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ipsen-biopharmaceuticals-joins-national-pharmaceutical-council-300429896.html


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. New 62,600 Square Foot Lease At 650 East Kendall Street Signed By Ipsen And BioMed Realty
2. Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
3. Ipsen and EpiVax collaborate to produce next generation botulinum toxins
4. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
5. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
6. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
7. PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals
8. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
9. Before the Bell Scans: Hologic Inc., St. Jude Medical Inc., ResMed Inc., and Navidea Biopharmaceuticals Inc.
10. Life Cycle Management of Biopharmaceuticals, New Life Science Webinar Hosted by Xtalks
11. Biopharmaceuticals - A Global Market Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... ... free webinar will review strategies for data management in modular and adaptive clinical ... times by up to 30 percent, reducing cost while increasing quality, achieving clinical site set-up ... to migrate data – reducing risk and impact on trial success, trial teams, and trial ...
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC has been ... EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma ... institution in Oklahoma to receive this prestigious endorsement. The award letter from ...
(Date:3/14/2019)... ... March 13, 2019 , ... ... 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium on 25–26 ... practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals have become ...
(Date:3/11/2019)... ... ... USDM Life Sciences and Generis have partnered to ... compliance for the life sciences industry. USDM Cloud Assurance delivers a transformative, ... for Generis’ flagship product, CARA. , Presentation One:, What: Cloud Assurance ...
Breaking Biology Technology:
(Date:3/1/2019)... (PRWEB) , ... March 01, 2019 , ... Geneious would ... provide an easy alternative to Vector NTI. , Geneious Prime already has ... lineage information from Vector NTI, so that files will be organised in Geneious in ...
(Date:2/27/2019)... ... , ... Circulomics is launching the Short Read Eliminator Kit to ... preparation. , This kit enhances long-read sequencing read lengths by using size selective ... damaged and recovered with high efficiency. Short DNA up to 25 kb in length ...
(Date:2/22/2019)... ... 2019 , ... As technology continues to drive the pace ... and medical science grows ever thinner. As medical machines and the computers that ... medical practice easier for doctors, more effective for patients and more cost effective ...
Breaking Biology News(10 mins):